| SZ CAT No: | CL-GMT-NO-11 |
| CAS No: | NA |
| Mol.F: | C36H63N3O13 |
| Mol.Wt.: | 745.91 |
| Chemical Name: | N-((2s,3r,4s,6r)-2-(((3r,5r,6r,7s,8s,9r,12r,13s,14r,15r,z)-12-ethyl-5,14-dihydroxy-8-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,7,9,13,15-hexamethyl-10-oxo-11,16-dioxa-2-azabicyclo[11.2.1]hexadec-1-en-6-yl)oxy)-3-hydroxy-6-methyltetrahydro-2h-pyran-4-yl)-n-methylnitrous amide |
| SMILES: | Smiles Not Available |
| Inventory Status: | Custom synthesis |
This impurity is related to N-Nitroso Gamithromycin Impurity 12 is provided with comprehensive characterization data in accordance with regulatory guidelines. It is suitable for use in analytical method development, method validation (AMV), Quality Control (QC) applications for Abbreviated New Drug Applications (ANDA) and commercial production of Asenapine.
N-Nitroso Gamithromycin Impurity 12 is used as a reference standard in analytical research. It ensures consistency of formulations.
Chemical Name:N-((2s,3r,4s,6r)-2-(((3r,5r,6r,7s,8s,9r,12r,13s,14r,15r,z)-12-ethyl-5,14-dihydroxy-8-(((2r,4r,5s,6s)-5-hydroxy-4-methoxy-4,6-dimethyltetrahydro-2h-pyran-2-yl)oxy)-3,5,7,9,13,15-hexamethyl-10-oxo-11,16-dioxa-2-azabicyclo[11.2.1]hexadec-1-en-6-yl)oxy)-3-hydroxy-6-methyltetrahydro-2h-pyran-4-yl)-n-methylnitrous amideCountry of Origin: India Product Category: Impurity Reference StandardAPI NAME: Gamithromycin Molecular Formula: C36H63N3O13
Molecular Weight: 745.91
Storage: Store in a cool, dry place.
Cat. No: CL-GMT-NO-01
CAS No: NA
Mol. F: C39H73N3O13
Mol. Wt: 791.1
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-001
CAS No: 145435-72-9
Mol. F: C40H76N2O12
Mol. Wt: 777.1
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-02
CAS No: 145259-55-8
Mol. F: C37H68N2O13
Mol. Wt: 749
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-03
CAS No: NA
Mol. F: C40H76N2O13
Mol. Wt: 793
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-04
CAS No: 145388-07-4
Mol. F: C37H70N2O12
Mol. Wt: 735
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-05
CAS No: NA
Mol. F: C40H76N2O12
Mol. Wt: 777.1
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-06
CAS No: 1797448-01-1
Mol. F: C32H62N2O9
Mol. Wt: 618.9
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-07
CAS No: 92594-48-4
Mol. F: C40H76N2O12
Mol. Wt: 777.1
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-08
CAS No: NA
Mol. F: C29H56N2O9
Mol. Wt: 476.8
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-09
CAS No: NA
Mol. F: C40H76N2O13
Mol. Wt: 793
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-10
CAS No: NA
Mol. F: C39H74N2O12
Mol. Wt: 763.01
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-11
CAS No: NA
Mol. F: C40H74N2O13
Mol. Wt: 791.02
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-03
CAS No: NA
Mol. F: C36H66N4O14
Mol. Wt: 778.94
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-04
CAS No: NA
Mol. F: C31H59N3O10
Mol. Wt: 633.82
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-05
CAS No: NA
Mol. F: C28H52N4O11
Mol. Wt: 620.74
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-06
CAS No: NA
Mol. F: C29H55N3O10
Mol. Wt: 605.77
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-07
CAS No: NA
Mol. F: C41H77N3O13
Mol. Wt: 820.08
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-08
CAS No: NA
Mol. F: C38H70N4O14
Mol. Wt: 806.99
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-09
CAS No: NA
Mol. F: C39H73N3O13
Mol. Wt: 792.02
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-NO-10
CAS No: NA
Mol. F: C37H67N3O14
Mol. Wt: 777.95
Inv. Status: Custom Synthesis
Cat. No: CL-GMT-12
CAS No: NA
Mol. F: C42H80N2O12
Mol. Wt: 805.1
Inv. Status: Custom Synthesis
| CAT No: | CL-GMT-NO-11 |
| CAS No: | NA |
| Mol.F: | C36H63N3O13 |
| Mol.Wt: | 745.91 |
Catalog No:
CAS No:
Mol. Formula:
Mol. Weight:
Chemical Name
Inv Status: